Integra Lifesciences Holdings (IART) Other Non-Current Assets (2009 - 2026)

Integra Lifesciences Holdings has reported Other Non-Current Assets for 18 years, with the latest figure at $31.6 million in Q2 2026.

• Quarterly Other Non-Current Assets fell 31.68% year-over-year to $31.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $31.6 million (down 31.68% YoY) and the FY2025 annual result came in at $37.9 million, down 43.05% from the prior year.
• Other Non-Current Assets retreated to $31.6 million in Q2 2026 per IART's latest filing, from $35.0 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $77.9 million in Q3 2023 and troughed at $29.5 million in Q1 2022.
• A 5-year average of $54.3 million and a median of $55.1 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 247.87% in 2022, then slumped 43.05% in 2025.
• Over 5 years, Other Non-Current Assets stood at $57.2 million in 2022, then grew by 1.76% to $58.2 million in 2023, then climbed by 14.3% to $66.5 million in 2024, then plunged by 43.05% to $37.9 million in 2025, then declined by 16.6% to $31.6 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $31.6 million, $35.0 million, and $37.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.